Iqvia decentralized clinical trial program achieves independent gdpr validation

Research triangle park, n.c.--(business wire)--iqvia (nyse:iqv), a leading global provider of advanced analytics, technology solutions and contract services to the life sciences industry, today announced its decentralized clinical trial (dct) program has received gdpr compliance validation from trustarc. this marks the first instance of a dct service receiving this european data privacy validation. trustarc's third-party validation demonstrates that iqvia's dct program processes personal data i
IQV Ratings Summary
IQV Quant Ranking